Literature DB >> 17653715

The oxidative status of blood cells in a murine model of graft-versus-host disease.

Johnny Amer1, Lola Weiss, Shoshana Reich, Michael Y Shapira, Shimon Slavin, Eitan Fibach.   

Abstract

We studied the oxidative status of red and white blood cells during the development of graft vs host disease (GVHD) as well as the effects of treatment with antioxidants, both in vitro and in vivo. (BALB/c X C57BL/6) F1 mice were conditioned by total body radiation and, 1 day later, transplanted with semi-allogeneic C57BL/6 spleen cells. GVHD was followed by its clinical manifestations. Oxidative stress in red blood cells (RBC), neutrophils, and lymphocytes was assessed by measuring generation of reactive oxygen species and the content of reduced glutathione by flow cytometry after gating of the specific populations. Oxidative stress was noticed 3 weeks after transplantation. It was higher in mice receiving allogeneic spleen cells as compared with mice transplanted with syngeneic cells, suggesting that it was associated with GVHD. The results also demonstrated that treatment with the antioxidants N-acetylcysteine and a derivative of vitamin E (tocopherol succinate, propofol), both in vitro and in vivo, reduced the oxidative stress. The results indicate that various blood cells, including RBC, neutrophils, and lymphocytes, are under oxidative stress and that treatment with antioxidants reduced the stress and, thus, may be useful in ameliorating the severe consequences of GVHD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17653715     DOI: 10.1007/s00277-007-0321-7

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  11 in total

1.  Proteomic analysis of murine bone marrow niche microenvironment identifies thioredoxin as a novel agent for radioprotection and for enhancing donor cell reconstitution.

Authors:  Ningfei An; Michael G Janech; Alison M Bland; John Lazarchick; John M Arthur; Yubin Kang
Journal:  Exp Hematol       Date:  2013-08-27       Impact factor: 3.084

2.  Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host disease.

Authors:  M Hanief Sofi; Yongxia Wu; Steven D Schutt; Min Dai; Anusara Daenthanasanmak; Jessica Heinrichs Voss; Hung Nguyen; David Bastian; Supinya Iamsawat; Shanmugam Panneer Selvam; Chen Liu; Nilanjana Maulik; Besim Ogretmen; Junfei Jin; Shikhar Mehrotra; Xue-Zhong Yu
Journal:  J Clin Invest       Date:  2019-05-02       Impact factor: 14.808

Review 3.  Distinct metabolic programs in activated T cells: opportunities for selective immunomodulation.

Authors:  Daniel R Wahl; Craig A Byersdorfer; James L M Ferrara; Anthony W Opipari; Gary D Glick
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

4.  Hemolysis exacerbates hyperfibrinolysis, whereas platelolysis shuts down fibrinolysis: evolving concepts of the spectrum of fibrinolysis in response to severe injury.

Authors:  Hunter B Moore; Ernest E Moore; Eduardo Gonzalez; Kirk C Hansen; Monika Dzieciatkowska; Michael P Chapman; Angela Sauaia; Bernadette West; Anirban Banerjee; Christopher C Silliman
Journal:  Shock       Date:  2015-01       Impact factor: 3.454

5.  The Green Tea Catechin Epigallocatechin Gallate Ameliorates Graft-versus-Host Disease.

Authors:  Sabine Westphal; Aleixandria McGeary; Sandra Rudloff; Andrea Wilke; Olaf Penack
Journal:  PLoS One       Date:  2017-01-19       Impact factor: 3.240

6.  Plasma vascular non-inflammatory molecule 3 is associated with gastrointestinal acute graft-versus-host disease in mice.

Authors:  Na Wang; Xiaoyi Qin; Yigeng Cao; Bin Liang; Kang Yu; Haige Ye
Journal:  J Inflamm (Lond)       Date:  2018-01-05       Impact factor: 4.981

7.  Ceruloplasmin is a potential biomarker for aGvHD following allogeneic hematopoietic stem cell transplantation.

Authors:  Meng Lv; Hai-ge Ye; Xiao-su Zhao; Xiang-yu Zhao; Ying-jun Chang; Dai-hong Liu; Lan-ping Xu; Xiao-jun Huang
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

8.  Thiol/redox metabolomic profiling implicates GSH dysregulation in early experimental graft versus host disease (GVHD).

Authors:  Jung H Suh; Bindu Kanathezhath; Swapna Shenvi; Hua Guo; Alicia Zhou; Anureet Tiwana; Frans Kuypers; Bruce N Ames; Mark C Walters
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

Review 9.  Hydrogen, a potential safeguard for graft-versus-host disease and graft ischemia-reperfusion injury?

Authors:  Lijuan Yuan; Jianliang Shen
Journal:  Clinics (Sao Paulo)       Date:  2016-09       Impact factor: 2.365

Review 10.  "Phage Transplantation in Allotransplantation": Possible Treatment in Graft-Versus-Host Disease?

Authors:  Andrzej Górski; Ewa Jończyk-Matysiak; Ryszard Międzybrodzki; Beata Weber-Dąbrowska; Jan Borysowski
Journal:  Front Immunol       Date:  2018-04-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.